Apeksha Joshi

475 citations
17 papers · 383 indexed · h-index 8

Apeksha Joshi

16 papers receiving 378 citations

Peers

Apeksha Joshi
Comparison fields: 5 of 76
  • Biomaterials 97
  • Endocrine and Autonomic Systems 35
  • Pharmaceutical Science 31
  • Aging 7
  • Molecular Biology 195
Replace Katia A. Mesquita with:
Katia A. Mesquita United Kingdom
Hamed Bagheri Iran
Yuxuan Dai China
Lifeng Luo China
Stefania Porto Italy
María José Guillén Spain
Shihui Bao China
Der‐An Tsao Taiwan
Daniel Moreno Spain
Attia Afzal Pakistan
Apeksha Joshi relative to Katia A. Mesquita United Kingdom Katia A. Mesquita's profile →
Citations per field
00.5×3.0×
Katia A. Mesquita · 1×
Citations per year

Countries citing papers authored by Apeksha Joshi

Since Specialization
Citations

This map shows the geographic impact of Apeksha Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Apeksha Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Apeksha Joshi more than expected).

Fields of papers citing papers by Apeksha Joshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Apeksha Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Apeksha Joshi. The network helps show where Apeksha Joshi may publish in the future.

Co-authorship network

The 18 scholars most cited alongside Apeksha Joshi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Apeksha Joshi Line = papers co-authored together Apeksha Joshi links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1 20250
2 20241
3 20231
4 202217
5 20221
6 202114
7 20211
8 20212
9 202140
10 20213
11 202042
12 201969
13 20197
14 201818
15 201870
16 19973
17
Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
198394

About Apeksha Joshi

Apeksha Joshi is a scholar working on Aging, Endocrine and Autonomic Systems and Biomaterials, having authored 17 papers that have together received 383 indexed citations. Recurring topics across this work include Circadian rhythm and melatonin (6 papers), Dietary Effects on Health (4 papers), Nanoparticle-Based Drug Delivery (4 papers), Genetics, Aging, and Longevity in Model Organisms (3 papers), Graphene and Nanomaterials Applications (3 papers), Alcohol Consumption and Health Effects (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Biomaterials (97 citations), Endocrine and Autonomic Systems (35 citations) and Pharmaceutical Science (31 citations). Apeksha Joshi has collaborated with scholars based in India, United States and Cameroon. Frequent co-authors include Ranjitsinh Devkar, Daniel Glaubiger, A Ramu, Ian Magrath, Sonal Thakore, Sriram Seshadri, Manita Das, Kapil K. Upadhyay, Ranjitsinh V. Devkar and Archana Solanki. Their work appears in journals such as Carbohydrate Polymers, Gastroenterology, Journal of Drug Delivery Science and Technology, Scientific Reports and The FASEB Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026